Constitutional asymmetry and pharmaceutical policy-making in the European Union (Record no. 15223)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01943naa a2200265uu 4500 |
| 001 - CONTROL NUMBER | |
| control field | 6032716063021 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20190211160825.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 060327s2005 xx ||||gr |0|| 0 eng d |
| 999 ## - SYSTEM CONTROL NUMBERS (KOHA) | |
| Koha Dewey Subclass [OBSOLETE] | PHL2MARC21 1.1 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | eng |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | PERMANAND, Govin |
| 9 (RLIN) | 23910 |
| 245 10 - TITLE STATEMENT | |
| Title | Constitutional asymmetry and pharmaceutical policy-making in the European Union |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Philadelphia, PA : |
| Name of publisher, distributor, etc. | Routledge, |
| Date of publication, distribution, etc. | 2005 |
| 520 3# - SUMMARY, ETC. | |
| Summary, etc. | This paper offers a theoretical perspective on pharmaceutical policy-making in the European Union, and shows the lack of a single European market in medicines to be the result of a clash between the supranational free movement rules and national healthcare policy competencies. The paper considers the roles of the European Commission, the member states, the industry and consumer interests (patients) as the main stakeholders, and frames the discussion within an integrated macro- and meso-level approach. Here we draw on Wilson's politics of (regulatory) politics typology, tying it to Scharpf's constitutional asymmetry perspective on EU policy. This enables the development of a broad sphere of analysis, allowing us to make observations on the EU regulatory arrangement for medicines as a whole. Specifically, the paper shows the extent to which industrial rather than health(care) policy interests have driven the development of regulatory policy in the sector, and seeks to understand the political dynamics shaping the on-going evolution of the regulatory framework. |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Constitutional asymmetry |
| 9 (RLIN) | 23911 |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | European Union |
| 9 (RLIN) | 17114 |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pharmaceuticals |
| 9 (RLIN) | 18723 |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Policy-making |
| 9 (RLIN) | 17297 |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Regulation |
| 9 (RLIN) | 16541 |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Single market |
| 9 (RLIN) | 17261 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | MOSSIALOS, Elias |
| 9 (RLIN) | 23912 |
| 773 08 - HOST ITEM ENTRY | |
| Title | Journal of European Public Policy |
| Related parts | 12, 4, p. 687 - 709 |
| Place, publisher, and date of publication | Philadelphia, PA : Routledge, 2005 |
| International Standard Serial Number | ISSN 1350-1763 |
| Record control number | |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Periódico |
| 998 ## - LOCAL CONTROL INFORMATION (RLIN) | |
| -- | 20060327 |
| Operator's initials, OID (RLIN) | 1606^b |
| Cataloger's initials, CIN (RLIN) | Natália |
| 998 ## - LOCAL CONTROL INFORMATION (RLIN) | |
| -- | 20100623 |
| Operator's initials, OID (RLIN) | 1242^b |
| Cataloger's initials, CIN (RLIN) | Carolina |
No items available.
